Last reviewed · How we verify
Vocamine (voacamine)
Vocamine (generic name: voacamine) is a drug. It is currently in unknown development.
Vocamine is thought to work by interacting with specific biological pathways, but the exact mechanism is unknown.
Voacamine is a naturally occurring small molecule dimeric indole alkaloid found in plants such as Voacanga africana and Tabernaemontana divaricata. It is approved for use as an antimalarial drug in several African countries and has been shown to exhibit cannabinoid CB1 receptor antagonistic activity.
At a glance
| Generic name | voacamine |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like a city with many different roads and intersections. Vocamine is like a small car that drives along those roads, interacting with the cells in a specific way to produce a desired effect. However, the exact route it takes and how it interacts with the cells is still a mystery.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vocamine CI brief — competitive landscape report
- Vocamine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Vocamine
What is Vocamine?
How does Vocamine work?
What is the generic name of Vocamine?
What development phase is Vocamine in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing